Rhian Gabe PhD , Philip A.J. Crosbie PhD , Daniel Vulkan MSc , Hannah Bailey M.B.B.S. , David R. Baldwin MD , Claire Bradley MBBCh , Richard Booton PhD , Michael J. Darby FRCR , Claire Eckert PhD , Neil Hancock BEng , Sebastian Hinde PhD , Sam M. Janes PhD , Martyn P.T. Kennedy MBChB , Catriona Marshall PhD , Henrik Moller Dr.Med. , Rachael L. Murray PhD , Richard D. Neal PhD , Samantha L. Quaife PhD , Suzanne Rogerson RN , Bethany Shinkins DPhil , Matthew E.J. Callister PhD
{"title":"Prospective Evaluation of Lung Cancer Screening Eligibility Criteria and Lung Cancer Detection in the Yorkshire Lung Screening Trial","authors":"Rhian Gabe PhD , Philip A.J. Crosbie PhD , Daniel Vulkan MSc , Hannah Bailey M.B.B.S. , David R. Baldwin MD , Claire Bradley MBBCh , Richard Booton PhD , Michael J. Darby FRCR , Claire Eckert PhD , Neil Hancock BEng , Sebastian Hinde PhD , Sam M. Janes PhD , Martyn P.T. Kennedy MBChB , Catriona Marshall PhD , Henrik Moller Dr.Med. , Rachael L. Murray PhD , Richard D. Neal PhD , Samantha L. Quaife PhD , Suzanne Rogerson RN , Bethany Shinkins DPhil , Matthew E.J. Callister PhD","doi":"10.1016/j.jtho.2024.12.016","DOIUrl":"10.1016/j.jtho.2024.12.016","url":null,"abstract":"<div><h3>Introduction</h3><div>Low-dose computed tomography screening for lung cancer reduces lung cancer mortality, but there is a lack of international consensus regarding the optimal eligibility criteria for screening. The Yorkshire Lung Screening Trial was designed to evaluate lung cancer screening (LCS) implementation, and a primary objective was prospective evaluation of three predefined eligibility criteria.</div></div><div><h3>Methods</h3><div>Individuals who had ever smoked, aged 55 to 80 years, who responded to written invitation, underwent telephone risk assessment and if eligible by at least one criterion (PLCO<sub>M2012</sub> ≥ 1.51%, LLP<sub>v2</sub> ≥ 5%, USPSTF<sub>2013</sub>) were offered biennial low-dose computed tomography screening.</div></div><div><h3>Results</h3><div>Of 44,957 individuals invited, 22,814 responded and underwent eligibility assessment, of whom a total of 7826 were eligible according to any of the three LCS criteria. Comparing PLCO<sub>M2012</sub> ≥ 1.51%, LLP<sub>v2</sub> ≥ 5%, and USPSTF<sub>2013</sub>, the proportions of responders eligible for screening were 28.0%, 20.5%, and 18.9%, respectively (<em>p</em> < 0.0001 for each comparison), and the proportion of all cancers detected 91.1%, 77.0%, and 62.8%, respectively (<em>p</em> ≤ 0.0002 for each comparison). When risk thresholds were selected to result in equivalent numbers of people eligible for screening, cancer detection proportions were higher for PLCO<sub>M2012</sub> (74.5%) and LLP<sub>v2</sub> (71.3%) than USPSTF<sub>2013</sub> (62.8%) (<em>p</em> = 0.0002 and <em>p</em> = 0.032, respectively), but there was no significant difference between the two risk models. Reducing the LLPv2 risk threshold from 5% to 2.5% (as currently used in the English LCS program) and reducing the pack-year requirement for the USPSTF<sub>2021</sub> versus the USPSTF<sub>2013</sub> criteria increased the numbers eligible for screening, but subsequent cancer yield was not measured in this study.</div></div><div><h3>Conclusion</h3><div>The PLCO<sub>M2012</sub> ≥ 1.51% criteria identified more people eligible for screening in Yorkshire Lung Screening Trial and resulted in more screen-detected lung cancers than LLP<sub>v2</sub> ≥ 5% or USPSTF<sub>2013</sub>. When compared in equivalent populations, there was no significant difference between risk models in terms of lung cancer detection and each appeared more efficient at screening population selection than USPSTF<sub>2013</sub>.</div></div>","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Pages 425-436"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142872435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Concerns Regarding Linear Assumptions in Principal Component Analysis: Advocating for Nonlinear and Nonparametric Approaches in Pulmonary Carcinoid Research","authors":"Yoshiyasu Takefuji PhD","doi":"10.1016/j.jtho.2024.12.024","DOIUrl":"10.1016/j.jtho.2024.12.024","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Pages e54-e55"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143785081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stephanie Tuminello PhD, Matthew Untalan MS, Raja Flores MD, Emanuela Taioli MD, PhD
{"title":"A Response to the Letter to the Editor: “Clinical Value of Incidental Lung Nodule Detection”","authors":"Stephanie Tuminello PhD, Matthew Untalan MS, Raja Flores MD, Emanuela Taioli MD, PhD","doi":"10.1016/j.jtho.2025.01.005","DOIUrl":"10.1016/j.jtho.2025.01.005","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Page e58"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143785174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rocky Shi , Dylan A. Farnsworth , Christopher A. Febres-Aldana , Justine LM. Chow , Ravinder Sheena , Tejveer Atwal , Juan Luis Gomez Marti , Kiersten N. Thomas , Che-Min Lee , Shannon J. Awrey , Paul C. McDonald , Romel Somwar , Shoukat Dedhar , Marc Ladanyi , Kevin L. Bennewith , William W. Lockwood
{"title":"PP01.09 Integrin-Linked Kinase Drives Drug-Tolerant Persister Cell Survival and EMT in Response to EGFR Inhibition in Lung Adenocarcinoma","authors":"Rocky Shi , Dylan A. Farnsworth , Christopher A. Febres-Aldana , Justine LM. Chow , Ravinder Sheena , Tejveer Atwal , Juan Luis Gomez Marti , Kiersten N. Thomas , Che-Min Lee , Shannon J. Awrey , Paul C. McDonald , Romel Somwar , Shoukat Dedhar , Marc Ladanyi , Kevin L. Bennewith , William W. Lockwood","doi":"10.1016/j.jtho.2025.03.017","DOIUrl":"10.1016/j.jtho.2025.03.017","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Page S6"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143759522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"PP01.25 Exploring the Impact of Socioeconomic and Geographic Factors on Immunotherapy Discontinuation and Success in Northern Ontario: A Retrospective, Single-Center Cohort Study","authors":"Alesha Bishop , Olexiy Aseyev","doi":"10.1016/j.jtho.2025.03.028","DOIUrl":"10.1016/j.jtho.2025.03.028","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Pages S10-S11"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143758991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"PP01.17 Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) as Independent Prognostic Markers in EGFR- Tested Advanced Non-small Cell Lung Cancer","authors":"Kijjakom Thanasombunsukh , Sukrit Treewattanawong","doi":"10.1016/j.jtho.2025.03.024","DOIUrl":"10.1016/j.jtho.2025.03.024","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Page S9"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143759186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Tobacco News Update–From the IASLC Tobacco Control Committee","authors":"","doi":"10.1016/j.jtho.2025.02.015","DOIUrl":"10.1016/j.jtho.2025.02.015","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Pages 408-410"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143785087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sarah Heynemann M.B.B.S., BMedSci, FRACP, MBioeth, Wendy Lipworth M.B.B.S., PhD, Sue-Anne McLachlan M.B.B.S., MSc, FRACP, Jennifer Philip M.B.B.S., GDipPallMed, MMed, PhD, Tom John M.B.B.S., PhD, FRACP, Ian Kerridge BA, BMed(Hons), MPhil(Cantab), FRACP, FRCPA
{"title":"A Response to “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC”","authors":"Sarah Heynemann M.B.B.S., BMedSci, FRACP, MBioeth, Wendy Lipworth M.B.B.S., PhD, Sue-Anne McLachlan M.B.B.S., MSc, FRACP, Jennifer Philip M.B.B.S., GDipPallMed, MMed, PhD, Tom John M.B.B.S., PhD, FRACP, Ian Kerridge BA, BMed(Hons), MPhil(Cantab), FRACP, FRCPA","doi":"10.1016/j.jtho.2024.12.017","DOIUrl":"10.1016/j.jtho.2024.12.017","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 4","pages":"Pages e51-e52"},"PeriodicalIF":21.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143785624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}